Thursday, July 25, 2019

FDA aims high in crackdown on CBD manufacturers - in-PharmaTechnologist

 By Ben Hargreaves
US FDA took aim at the ‘world’s largest cannabis’ company for making ‘unfounded claims’ about the therapeutic potential of its CBD products.

You might also be interested in:   FDA cGMP QSR GMP Online Training Courses

No comments:

From SkillsPlus International Inc.